[Fatty liver].
Andrade
R J
RJ
García-Escaño
M D
MD
D000328:Adult; D000975:Antioxidants / Q000627:therapeutic use; D002756:Cholagogues and Choleretics / Q000627:therapeutic use; D003430:Cross-Sectional Studies; D048909:Diabetes Complications; D005234:Fatty Liver / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000453:epidemiology; D005235:Fatty Liver, Alcoholic / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000453:epidemiology; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications; D010865:Pilot Projects; D011379:Prognosis; D012307:Risk Factors; D013030:Spain / Q000453:epidemiology; D014463:Ultrasonography; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use
D000975:Antioxidants; D002756:Cholagogues and Choleretics; D014810:Vitamin E; D014580:Ursodeoxycholic Acid